Most people walk into my office expecting an adjustment and maybe an ice pack. So when I explain that we can deliver acoustic energy through their heel to repair a tendon without needles, drugs, or surgery, they usually ask the obvious question: is that real?
It is. SoftWave therapy (formally SoftWave TRT, for tissue regeneration therapy) is one of the most evidence-backed non-surgical tools in musculoskeletal medicine right now, and I want to explain exactly why I reach for it, what it does inside tissue, and when it genuinely makes sense for a patient.
What SoftWave Actually Is (Not to Be Confused with Basic Shockwave)
SoftWave therapy falls under the umbrella of shockwave therapy, but with a meaningful distinction: it uses unfocused, broad-aperture acoustic waves generated by a patented electrohydraulic spark-gap mechanism. Most shockwave devices use either tightly focused or radial pressure waves. SoftWave’s technology produces a wider, lower-pressure wave that penetrates deeper tissue without the point-source intensity of focused systems.
The clinical difference matters. Focused shockwave delivers energy to a precise, small target area. SoftWave’s wider aperture covers more tissue per session, which is why it tends to work efficiently for larger treatment zones such as the hip or lumbar fascia. At our clinic in West Linn, we use SoftWave TRT for conditions where we want biological tissue repair, not just temporary symptom relief.
The Cellular Mechanism: Why Acoustic Waves Trigger Healing
This is the part most clinicians skip, but it is the part that matters most for understanding why shockwave therapy near me might be worth a visit.
When the acoustic wavefront contacts tissue, it creates a transient mechanical stress. At therapeutic doses, that stress is not destructive. Instead, it activates several interlocking biological repair pathways:
Mechanotransduction and stem cell recruitment. The pressure change triggers mechanoreceptors on cell surfaces, which upregulate vascular endothelial growth factor (VEGF) and transforming growth factor beta-1 (TGF-B1). These signaling proteins recruit mesenchymal stem cells to the treatment area. A 2022 study from the University of Vienna confirmed that a single SoftWave session produced a measurable increase in CD90-positive stem cell migration in tendon tissue within 72 hours.
Angiogenesis. VEGF upregulation stimulates new capillary formation. This is the vascular infrastructure that chronically degenerated tissue (tendinopathy, fasciitis, calcific deposits) has often lost. You cannot heal tissue with inadequate blood supply. Shockwave restores it.
Mast cell degranulation and inflammatory modulation. SoftWave initiates a controlled, acute inflammatory signal through substance P release and mast cell activation. This sounds counterintuitive for a pain treatment, but it is precisely the point: many chronic musculoskeletal conditions are stuck in a degenerative phase, not a true inflammatory phase. The wave essentially reboots the tissue repair sequence.
Piezoelectric effect on calcific deposits. For calcific tendinitis, acoustic waves mechanically fragment calcium hydroxyapatite crystals and promote macrophage reabsorption. A 2024 meta-analysis published in the British Journal of Sports Medicine reported an 82% reduction in calcific volume on ultrasound at 12 weeks post-treatment.
I explain it to patients this way: your tendon stopped healing on its own because the biology stalled. SoftWave restarts the process by speaking the tissue’s own mechanical language.
What the Evidence Actually Shows
I am direct with patients about this: SoftWave therapy has strong clinical trial support for specific conditions, and weaker evidence for others.
For chronic plantar fasciitis, the evidence is definitive. Multiple randomized controlled trials, including a 2023 multicenter trial published in Foot and Ankle International, confirm that extracorporeal shockwave therapy produces superior outcomes to corticosteroid injection at 12-week follow-up. SoftWave’s unfocused delivery protocol was used in several of these trials.
For chronic Achilles tendinopathy, a 2025 Cochrane review found shockwave therapy (including unfocused protocols) significantly outperformed sham treatment for pain reduction and functional improvement at 6-month follow-up.
For rotator cuff tendinopathy and calcific tendinitis of the shoulder, the evidence is also strong. For lateral epicondylitis (tennis elbow), results are consistently good. For gluteal tendinopathy and hamstring origin tendinopathy, the data is promising but trial volume is smaller.
For low back pain as a standalone treatment, the evidence is mixed, and I do not recommend SoftWave as a primary intervention there. I use it as an adjunct to spinal manipulation and corrective exercise when a specific soft tissue component is identified on examination.
What SoftWave Won’t Do (And Who Should Not Have It)
Non-surgical pain relief is a real category, and SoftWave fits in it. But clarity matters.
SoftWave will not repair a full-thickness structural tear. If you have a complete Achilles rupture or a full-thickness rotator cuff tear, you need a surgical consultation, not acoustic waves. SoftWave is designed for degenerative tendinopathy and partial-thickness pathology.
It is not a substitute for rehabilitation exercise. The biological repair SoftWave initiates needs mechanical loading to organize properly. We pair every SoftWave course of treatment with a structured exercise protocol. Patients who skip the rehab component tend to get partial, shorter-lived results.
Absolute contraindications include: open growth plates in skeletally immature patients, active malignancy near the treatment site, coagulation disorders or active anticoagulant therapy, local infection, and pregnancy. Patients with cardiac pacemakers should be evaluated individually depending on treatment site proximity.
It is also not a one-session fix. A standard protocol runs 3 to 6 sessions at weekly intervals. Most patients notice meaningful improvement by session 3, with continued tissue remodeling over the following 8 to 12 weeks. I tell patients to assess final results at 3 months, not 3 weeks.
How We Use SoftWave at Gentle Care Chiropractic in West Linn
At our West Linn, Oregon clinic, SoftWave is integrated into a broader musculoskeletal care plan, not offered as an isolated service. That distinction matters.
Before I recommend it, I want to know: what is the tissue diagnosis? Degenerative tendinopathy, partial tear, and enthesopathy behave differently and have different treatment timelines. What has already been tried? Is there a biomechanical loading problem contributing to the condition in the first place? Treating tendinopathy without correcting the loading pattern that caused it is incomplete care.
When the indication is right, SoftWave TRT produces results I find consistently reliable. The patients who respond best are those with chronic, treatment-resistant tendinopathy who have already tried physical therapy and injections without durable relief. If that sounds like you, it is worth having a conversation about whether SoftWave makes sense for your specific presentation.
If you have questions or want to find out whether SoftWave therapy is a good fit for your care plan, we’re easy to reach. That’s what we’re here for.
Dr. Tristan Santiago Maceiras is a Doctor of Chiropractic at Gentle Care Chiropractic in West Linn, Oregon, specializing in musculoskeletal medicine, MVA recovery, and integrated care.
Frequently Asked Questions: SoftWave Therapy
Is SoftWave therapy the same as shockwave therapy near me?
SoftWave TRT is a type of shockwave therapy, but not all shockwave devices are equivalent. SoftWave uses unfocused electrohydraulic technology that treats a broader tissue zone per session compared to focused devices. The protocol, the device type, and the provider’s diagnostic approach all affect outcomes. If you’ve searched for shockwave therapy near West Linn, it is worth asking specifically which device and protocol a clinic uses.
How many SoftWave sessions will I need?
Most conditions require 3 to 6 sessions, spaced approximately one week apart. Chronic plantar fasciitis often responds well in 3 to 4 sessions. Calcific tendinitis of the shoulder typically requires the full 6. Tissue remodeling continues for 8 to 12 weeks after your last session, so I assess final results at 3 months.
Does SoftWave therapy hurt?
Most patients describe it as a dull pressure or mild aching sensation during treatment. It is not painless, but it is well-tolerated without anesthesia or numbing agents. We adjust intensity in real time based on patient feedback, and the treatment window is typically 10 to 15 minutes.
Can SoftWave replace surgery for plantar fasciitis?
For chronic plantar fasciitis that has not responded to conservative care, SoftWave therapy is one of the most effective non-surgical options available. The clinical trial data strongly supports it as a first-line intervention before considering surgical release. That said, a full biomechanical evaluation is necessary before deciding on any pathway, because foot structure and loading mechanics vary considerably between patients.
Is SoftWave covered by insurance?
Most insurance plans do not currently cover SoftWave TRT or extracorporeal shockwave therapy. Most payers classify it as an emerging technology. We offer transparent cash-pay pricing and discuss all options during your initial consultation at our West Linn clinic. For patients with personal injury claims or workers’ compensation cases, coverage pathways may differ and we can help you navigate those.
Dealing with this in West Linn, Lake Oswego or Oregon City?
Same-week appointments. PIP and most insurance accepted.